Literature DB >> 21300014

Surgical technique of temporary arterial occlusion in the operative management of spinal hemangioblastomas.

Aaron J Clark1, Daniel C Lu, R Mark Richardson, Tarik Tihan, Andrew T Parsa, Dean Chou, Nicholas M Barbaro, Sandeep Kunwar, Philip R Weinstein, Michael T Lawton, Mitchel S Berger, Michael W McDermott.   

Abstract

BACKGROUND: Spinal hemangioblastomas (SH) are definitively treated by en bloc microsurgical resection. Although benign, their highly vascular nature makes resection challenging. A major difficulty involves intraoperative differentiation of vessels supplying the tumor from those supplying the spinal cord.
METHODS: Twenty patients with SH treated surgically at a single institution were reviewed. Median age was 49 years (range 24 to 70 years). Eleven patients had von Hippel-Lindau syndrome. Six underwent preoperative angiography, of which five underwent embolization. All tumors were posterior and resected through a laminectomy approach. Temporary arterial occlusion (TAO) by aneurysm clip placement with concurrent neuromonitoring was used at the tumor edge to differentiate arteries supplying the tumor from those supplying the healthy spinal cord. Arteries were assumed to not supply important regions of the cord and divided at the tumor surface if there was no change in evoked potentials after 4 minutes of occlusion.
RESULTS: Of the 20 patients, 5 improved, 13 remained stable, and 2 worsened. Of the five treated with TAO, two improved, three remained stable, and none worsened. Median McCormick's functional grade of patients treated with TAO was II and improved to I after the operation, whereas that of those not treated with TAO remained unchanged at II (Wilcoxon rank-sum, P = .35).
CONCLUSIONS: Temporary arterial occlusion with neuromonitoring is a safe, effective, and simple method of differentiating arteries supplying the tumor only from those that supply the functionally normal spinal cord in the operative management of difficult SH.
Copyright © 2010. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21300014     DOI: 10.1016/j.wneu.2010.03.016

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  7 in total

1.  Visualization of vascular structure of spinal hemangioblastoma using intraoperative indocyanine green videoangiography and temporary feeder occlusion.

Authors:  Yasuhiro Takeshima; Yoshitaka Tanaka; Yasuo Hironaka; Yoichi Shida; Hiroyuki Nakase
Journal:  Eur Spine J       Date:  2015-01-07       Impact factor: 3.134

2.  Spinal hemangioblastomas: analysis of surgical outcome and prognostic factors.

Authors:  Alberto Feletti; Alessandro Boaro; Davide Giampiccolo; Giorgio Casoli; Fabio Moscolo; Massimiliano Ferrara; Francesco Sala; Giacomo Pavesi
Journal:  Neurosurg Rev       Date:  2021-11-25       Impact factor: 3.042

Review 3.  Contiguous haemangioblastomas of the brain and spine in a patient of Von Hippel-Lindau disease.

Authors:  Asifur Rahman; Saif Ul Hoque; Paawan Bahadur Bhandari; Shamsul Alam
Journal:  BMJ Case Rep       Date:  2013-01-22

4.  Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von Hippel-Lindau disease.

Authors:  Ali Harati; Jarno Satopää; Lydia Mahler; Romain Billon-Grand; Ahmed Elsharkawy; Mika Niemelä; Juha Hernesniemi
Journal:  Surg Neurol Int       Date:  2012-01-21

5.  Successful surgical strategy for a cervical hemangioblastoma: Case report.

Authors:  Hideaki Imai; Kazuhiko Ishii; Hirotaka Chikuda; Junichi Ohya; Daichi Nakagawa; Tomomasa Kondo; Seiji Nomura; Masanori Yoshino; Satoru Miyawaki; Taichi Kin; Hirofumi Nakatomi; Nobuhito Saito
Journal:  Surg Neurol Int       Date:  2016-09-22

6.  Microsurgical Resection of Spinal Cord Hemangioblastoma: 2-Dimensional Operative Video.

Authors:  Mirza Pojskic; Kenan I Arnautovic
Journal:  Oper Neurosurg (Hagerstown)       Date:  2018-12-01       Impact factor: 2.703

Review 7.  Surgical Treatment of Intramedullary Hemangioblastomas: Current State of Problem (Review).

Authors:  S Yu Timonin; N A Konovalov
Journal:  Sovrem Tekhnologii Med       Date:  2021-10-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.